SUMMARY The therapeutic activity of a single 2 g dose of secnidazole was studied in patients with urogenital trichomoniasis. In 140 patients, 97 % were cured and the drug was well tolerated. In the laboratory, tests on sensitivity were made and the minimal inhibitory concentration (MIC) and the minimal trichomonacidal concentration (MTC) were determined on cultures that had recently been isolated at the clinic, and the pharmacokinetic properties of secnidazole in man were compared with those of tinidazole. The therapeutic efficacy of all the metronidazole derivatives was reviewed and a single-dose treatment is recommended. Therapeutic and prophylactic treatment is achieved by products with a long half-life. Secnidazole, with a half-life of 14-3± 1*3 h (women) and 20 2+3 1 h (men), is particularly suitable for this type of treatment.
Introduction
Patients and methods
Urogenital trichomoniasis is a common sexually transmitted disease (STD). Recent studies by
French workers in Paris, Corsica, and Senegal showed that 20 to 25 % of women and 15 % of men who have a non-gonococcal genital infection are infected by this parasite (Nicoli et al., 1964; Ridet and Siboulet, 1974-75, unpublished; Bohbot, 1975) . As a result of this work and because of the current epidemiological need for a single-dose treatment (treatment 'within a minute') (Siboulet and Durel, 1961; Csonka, 1971) , the interest of clinicians has been focused on new products.
Two studies, one clinical and one laboratory, have been carried out in parallel on a new derivative of 5-nitroimidazole-14 539 RP or secnidazole. In the laboratory study, the biological activity and pharmacokinetic properties of secnidazole were compared with those of metronidazole and tinidazole. The half-life of secnidazole made it especially interesting, particularly for the type of treatment stated above.
One hundred and forty patients (56 men and 84 women) aged between 15 and 54 years, were treated at two centres with one 2 g dose of secnidazole (4 x 500 mg tablets). Pregnant women were not included in the trial. To complete the study a larger dose (2 5 g) was given to 110 patients to find out if this improved the rate of cure. Patients in the second group matched patients in the first in respect of mean age, marital state, and the number of sexual partners treated at the same time.
The importance of hygiene and of having an adequate diet was stressed and each patient was told that the partner(s) must be given treatment simultaneously.
Diagnostic and control samples were taken as previously described (Siboulet et al., 1977) . The samples were examined microscopically-phase contrast and May-Grunwald-Giemsa stain-and cultured on Roiron's isolation medium Wallin and Forsgren (1974) , modified by substituting Dubost medium (Cosar et al., 1962) for the Diamond medium (Diamond, 1957) , as the latter is too rich and allows too great a growth rate for the sensitivity test. Details of the techniques are given elsewhere (Siboulet et al., 1977) . The MIC and MTC estimations were made on 11 strains (one reference standard, maintained in the laboratory for 20 years, and 10 strains freshly isolated from humans) for each of the three drugsmetronidazole, secnidazole, and tinidazole.
In addition we studied serum concentrations for the three products both physicochemically (Populaire et al., 1977, personal communication) and microbiologically (Cosar et al., 1962; Videau, 1972) and obtained the same results. This was carried out by taking blood samples 1, 2, 3, 6, 9, 12, 24, 48, and 72 hours after a single oral dose (2 g) of each drug had been administered to 10 volunteers* (five men and five women). With the assay procedure the standard deviation was 7% and half-lifes were calculated according to the methods of Riegelman et al. (1968) and Ritschel (1970) .
Results
The single 2 g dose was curative at 48 hours in 136 (97.1 %) of the 140 patients treated (Table 1) Table 3 .
Lastly, the serum drug-clearance curves, obtained after oral administration of 2 g of secnidazole or tinidazole (mean of 10 volunteers) are given with standard error of the mean in the Figure, as well as the curve for metronidazole, for the same 2 g dose, taken from the literature (Wood and Monro, 1975) . 
Discussion
With a single 2 g dose, 971% of the patients were cured, while the 3 % failures responded to further doses of the drug (Table 1 ). There were 6-7 % long-term relapses (on day 15) which may be related not only to the menstrual cycle and the probable presence of persistent forms of trichomonads but also to reinfection.
The values for metronidazole (90 to 920%) and tinidazole (96 %) given by Wallin and Forsgren (1974) and 94% given by Swarz (1974) Korner and Jensen (1976) .
The study of the MTC showed that secnidazole continued to act on the parasite after being subcultured in a fresh medium and that the mean value of the MTC was always lower than that of the MIC. Statistical analysis (Student's t test) showed no significant difference in the trichomonacidal effect of the three drugs, but the mean lethal values for each drug bore the same relationship to the MIC values.
We agree completely with Wood and Monro (1975) 
